Tirzepatide is the newer, more powerful option, a dual-action GLP-1/GIP receptor agonist that produces weight loss numbers researchers have never seen from any other medication
View our plans & pricing page for more detailed plan and pricing options
Obesity 28(6):10501061 Kusminski CM, Perez-Tilve D, Mller TD, DiMarchi RD, Tschp MH, Scherer PE (2024) Transforming obesity: The advancement of multi-receptor drugs
Our formulation is adjusted to this range
This is why tendonitis frequently affects athletes, tradespeople, and individuals whose work involves repetitive arm, wrist, or leg movements, such as typing, painting, or running
A double-blind, placebo-controlled trial on CB4211, which is an analog (synthetic version) of MOTS-c, found the compound to be "safe and well tolerated" under a single and multiple ascending dose protocol in adult humans